Key Insights

Highlights

Treatment Research

1 treatments under study, led by Fosfomycuntrometamol

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

0.0%

0 terminated out of 1 trials

Late-Stage Pipeline

100%

1 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

1Total
Phase 3 (1)

Trial Status

Not Yet Recruiting1

Clinical Trials (1)

Research Network

Common Treatments

  • Fosfomycuntrometamol1

Active Sponsors

  • INSERM UMR1311 DYNAMICURE1
  • Health Ministry funding (ReSpiR funds)1
  • Department of General Practice, Rouen University1
  • University Hospital, Rouen1

Top Investigators

Related Conditions

  • Cystitis1
  • Urinary Tract Infection1
  • Prostatitis1

Activity Timeline